List of Therapeutic Companies in Slovakia - 2

AXON Neuroscience is a clinical-stage biotech company founded in 1999 with a specialized team of researchers focused exclusively on tau immunotherapies and tau diagnostic platforms. AXON has identified and wholly owns several compounds which are being investigated as potentially disease-modifying therapies for the treatment of Alzheimer's disease and other tauopathies. The two lead compounds are the active vaccine AADvac1 and the monoclonal antibody AADvac2. The tau vaccine AADvac1 has potential to be the first breakthrough therapy to address Alzheimer's disease and help millions of people suffering from the devastating disease. Axon is also developing a suite of diagnostic assays to more accurately identify patients with potential tau-derived brain diseases that can benefit from its novel therapeutic candidates.

Personalized cancer immunotherapy for aggressive hypoxic tumors with blockbuster potential. Our Target Mechanism For Treating Hypoxic Tumors: Carbonic Anhydrase IX (CA IX). Our Mission: - to fill the gap in treatment of oncology diseases with poor prognosis, - to increase survival rate and bring hope to patients who have undergone different types of therapies without success, - to deliver novel therapeutics that match the principle of personalized medicine which will help patients to improve the quality of their lives. Crunchbase https://www.crunchbase.com/organization/mabpro-therapeutics